CBAK Energy Technology Inc
LSE:0A98
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CBAK Energy Technology Inc
LSE:0A98
|
CN |
|
B
|
Biotest AG
XBER:BIO
|
DE |
|
M
|
MedMira Inc
F:47M
|
CA |
|
N
|
Nebius Group NV
DUS:YDX
|
NL |
|
Smooth Rock Ventures Corp
OTC:SMRVF
|
CA |
|
T
|
Trinity Biotech PLC
SWB:TRBA
|
IE |
Wall St Price Targets
0A98 Price Targets Summary
CBAK Energy Technology Inc
According to Wall Street analysts, the average 1-year price target for
0A98 is 1.54 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A98's stock price target?
Price Target
1.54
USD
According to Wall Street analysts, the average 1-year price target for
0A98 is 1.54 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.
What is the Revenue forecast for CBAK Energy Technology Inc?
Projected CAGR
54%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 2 years is 54%.